直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan

Search Finnegan

Our Insights

24 results

Federal Circuit IP Blog

Licenses Do Not Require Nexus to Specific Claims to Be Objective Evidence of Nonobviousness, and Substantial Licensing Fees Should Be Given the Significance That Their Magnitude Deserves Licenses Do Not Require Nexus to Specific Claims to Be Objective Evidence of Nonobviousness, and Substantial Licensing Fees Should Be Given the Significance That Their Magnitude Deserves

June 27, 2025

Federal Circuit IP Blog

Federal Circuit Affirms PTAB’s Obviousness Analysis for Recessed Lighting Patent Federal Circuit Affirms PTAB’s Obviousness Analysis for Recessed Lighting Patent

April 29, 2025

Articles

Recent Filings and Decisions for Standard Essential Patents July and August 2024: U.S. CAFC, District Courts, PTAB, and European Courts

Recent Filings and Decisions for Standard Essential Patents July and August 2024: U.S. CAFC, District Courts, PTAB, and European Courts Recent Filings and Decisions for Standard Essential Patents July and August 2024: U.S. CAFC, District Courts, PTAB, and European Courts

October 18, 2024

At the PTAB Blog

PTAB Denies IPR Challenging Patent Relating to a Prenatal Vitamin PTAB Denies IPR Challenging Patent Relating to a Prenatal Vitamin

November 22, 2022

Webinar

Billion Dollar Patents: Building a Strong Patent Portfolio, Generating Value, Protecting IP Billion Dollar Patents: Building a Strong Patent Portfolio, Generating Value, Protecting IP

September 8, 2022

Webinar

At the PTAB Blog

Second Arthrex Petition Granted to Vacate PTAB Decision Second Arthrex Petition Granted to Vacate PTAB Decision

December 3, 2021

At the PTAB Blog

PTAB Finds Secondary Considerations Support a Finding of Nonobviousness of a Mechanical Invention PTAB Finds Secondary Considerations Support a Finding of Nonobviousness of a Mechanical Invention

November 9, 2021

Webinar

When Novelty and Non-obviousness Aren’t Enough: Meeting the Requirements of Sufficiency, Enablement and Clarity in Chemical and Life Sciences Cases

When Novelty and Non-obviousness Aren’t Enough: Meeting the Requirements of Sufficiency, Enablement and Clarity in Chemical and Life Sciences Cases When Novelty and Non-obviousness Aren’t Enough: Meeting the Requirements of Sufficiency, Enablement and Clarity in Chemical and Life Sciences Cases

October 28, 2021

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP